| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.051 | 0.8 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.067 | 0.8 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |